https://theorg.com/org/keros-therapeutics?person=esther-cho
Keros Therapeutics | The Org
Keros is dedicated to discovery and development of novel therapeutics for hematological and musculoskeletal disorders.
keros therapeutics
https://www.macrotrends.net/stocks/charts/KROS/keros-therapeutics/cash-on-hand
Keros Therapeutics Cash on Hand 2020-2026 | KROS | MacroTrends
Keros Therapeutics cash on hand from 2020 to 2026. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at...
cash on handkeros therapeutics20202026kros
https://www.annualreports.com/Company/keros-therapeutics-inc
Keros Therapeutics, Inc. - AnnualReports.com
keros therapeuticsinc
https://theorg.com/org/keros-therapeutics/teams/leadership-team
Keros Therapeutics - Leadership Team | The Org
The Leadership Team at Keros Therapeutics is responsible for setting the strategic direction and overseeing the company's operations in the discovery and...
keros therapeuticsleadership team
https://www.fiercebiotech.com/keyword/keros-therapeutics
Keros Therapeutics | Fierce Biotech
keros therapeuticsfiercebiotech
https://theorg.com/org/keros-therapeutics
Keros Therapeutics | The Org
Keros is dedicated to discovery and development of novel therapeutics for hematological and musculoskeletal disorders.
keros therapeutics
https://www.biospace.com/keros-therapeutics-announces-leadership-updates-june-17-2024
Keros Therapeutics Announces Leadership Updates - June 17, 2024 - BioSpace
Jun 18, 2024 - Keros Therapeutics, Inc. announced changes to its Board of Directors and Executive Committee, effective July 1, 2024.
keros therapeuticsleadership updatesjune 17announces2024
https://www.biospace.com/press-releases/keros-therapeutics-announces-initial-topline-results-from-the-phase-1-clinical-trial-of-ker-065-in-healthy-volunteers
Keros Therapeutics Announces Initial Topline Results from the Phase 1 Clinical Trial of KER-065 in...
https://www.biospace.com/keros-therapeutics-to-present-at-the-28th-annual-congress-of-the-european-hematology-association
Keros Therapeutics to Present at the 28th Annual Congress of the European Hematology Association -...
May 12, 2023 - Keros Therapeutics, Inc. announced that three abstracts will be presented from the KER-050 and ALK2 hematology programs at the 28th Annual Congress of the...